University Of Texas/Texas Am Investment Management Co's Form 4 filing
Rein Therapeutics, Inc. (RNTX) · filed Jun 7, 2024
- Accession no.
- 0001019231-24-000024
- Filed
- Jun 7, 2024
- Trade date
- Jun 5-7, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market sales total $40.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| University Of Texas/Texas Am Investment Management CoCIK 0001019231 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | Common Stock | SSaleDisposed | −6,291 | $3.30 | −$20,760.3 | 1,783,851 | Direct | |
| Jun 6, 2024 | Common Stock | SSaleDisposed | −1,100 | $3.27 | −$3,597 | 1,782,751 | Direct | |
| Jun 6, 2024 | Common Stock | SSaleDisposed | −3,184 | $3.30 | −$10,507.2 | 1,779,567 | Direct | |
| Jun 7, 2024 | Common Stock | SSaleDisposed | −1,564 | $3.25 | −$5,083 | 1,778,003 | Direct | |
| Jun 7, 2024 | Common Stock | SSaleDisposed | −176 | $3.30 | −$580.8 | 1,777,827 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.